Zambia ZAMRA Pharmaceutical Registration Guide

ZAMRA: The Regulator

The Zambia Medicines Regulatory Authority (ZAMRA) was established under the Medicines and Allied Substances Act (No. 3 of 2013), replacing the former Pharmacy and Poisons Board. ZAMRA is the national regulatory authority responsible for ensuring the quality, safety, and efficacy of medicines, medical devices, and allied substances in Zambia.

ZAMRA's core functions:

• Product registration and marketing authorization
• Inspecting manufacturing facilities (GMP audits)
• Issuing import and export permits
• Pharmacovigilance and post-market surveillance
• Clinical trial authorization
• Licensing of pharmacies and drug outlets

ZAMRA is headquartered in Lusaka (at the ZAMRA House on Chishango Road) with regional offices in Kitwe, Livingstone, and Chipata. The authority has implemented an electronic submission system called the ZAMRA Online Portal, though the system is less sophisticated than Kenya's or South Africa's. Paper submissions are still accepted.

Registration Pathways & Product Categories

ZAMRA offers multiple registration pathways aligned with SADC and WHO standards.

Pathway 1: Full Registration (New Chemical Entities / NCEs)

Full clinical trial data required. Timeline: 12-18 months. Rare for most exporters.

Pathway 2: Abridged Registration (Generic Products)

The most common pathway for imports. Requires bioequivalence data or reference to a registered product. Timeline: 8-14 months.

Pathway 3: SADC Harmonization (ZaZiBoNa)

This is the strategic pathway for Southern Africa. The ZaZiBoNa collaborative registration process involves Zambia, Zimbabwe, Botswana, Namibia, and South Africa. One dossier assessed by multiple SADC countries. Timeline: 6-10 months for collaborative assessment.

Pathway 4: WHO PQ Recognition (Fast-Track)

Products with WHO Prequalification receive priority review. Timeline: 4-7 months.

Pathway 5: SRA Recognition

Products approved by US FDA, EMA, or other SRAs receive accelerated review. Timeline: 5-8 months.

Pathway 6: Locally Manufactured Products

Products manufactured in Zambia receive priority processing (3-6 months) and government procurement preferences.

Prerequisites: What You Need Before Applying

Before submitting to ZAMRA, ensure these items are in place.

• Appoint a Local Agent/Distributor: Foreign manufacturers must appoint a Zambian company with a valid ZAMRA import license. This agent will hold the registration and manage importation.
• Execute a Power of Attorney (PoA): A notarized document authorizing your local agent. Must be legalized at the Zambian embassy.
• Obtain a Certificate of Pharmaceutical Product (CPP): Issued by your home regulator. Must be in WHO format, less than 2 years old, and legalized.
• Prepare Your Dossier in CTD Format: ZAMRA follows the CTD format (Modules 1-5).
• WHO PQ or SRA Approval (if available): The single most valuable document for accelerated registration.
• Product Samples: Required for ZAMRA laboratory testing in Lusaka.

Step-by-Step Registration Process

Here's the actual process for registering with ZAMRA. It's moderate in complexity.

Step 1: Appoint a Local Agent

Sign an agreement with a Zambian importer. Verify their ZAMRA license and their experience with product registration and ZAMSC tenders.

Step 2: Execute and Legalize Power of Attorney

Draft PoA, notarize, legalize at Zambian embassy. No translation required. This takes 2-3 weeks.

Step 3: Prepare Your CTD Dossier

Compile CTD dossier (Modules 1-5) in PDF format. ZAMRA accepts electronic submissions via their online portal.

Step 4: Pre-Submission Meeting (Optional)

Your agent can request a meeting with ZAMRA evaluators. Recommended for complex products or first-time applicants.

Step 5: Online Submission via ZAMRA Portal

Your agent uploads the dossier, pays the application fee (ZMW 2,000-5,000/$80-200), and receives an acknowledgement.

Step 6: Administrative Screening (3-5 weeks)

ZAMRA checks for completeness, legalization, and format. Deficiency letters add 3-5 weeks per cycle.

Step 7: Scientific Evaluation (5-10 months)

ZAMRA evaluators review quality, bioequivalence (if applicable), and labeling. Queries issued via portal. You have 60-90 days to respond.

Step 8: ZaZiBoNa Verification (if applicable - 1-2 months)

If using the SADC harmonization pathway, ZAMRA coordinates with other participating countries.

Step 9: Laboratory Testing (1-2 months)

ZAMRA's quality control laboratory in Lusaka tests product samples. Failure = rejection.

Step 10: GMP Inspection (If Required)

ZAMRA may inspect foreign facilities. WHO PQ or SRA approval typically waives inspection.

Step 11: ZAMRA Registration Committee Approval (3-5 weeks)

Final approval and certificate issuance.

Dossier Requirements: The ZAMRA CTD Format

ZAMRA follows the CTD format (Modules 1-5), aligned with WHO and SADC standards.

Module 1: Administrative Information (Zambia-Specific)

• Application letter on manufacturer letterhead
• Cover letter from Zambian agent
• Power of Attorney (legalized)
• Certificate of Pharmaceutical Product (WHO format, legalized, less than 2 years old)
• GMP Certificate (legalized)
• Free Sale Certificate
• Manufacturing license
• Labeling and package insert (English)
• WHO PQ certificate or SRA approval (if available)

Module 2: Summaries

Module 3: Quality

• Stability data: Zambia has a tropical climate (hot and humid in most areas). Zone IV data is recommended.

Module 4: Nonclinical (NCEs only)

Module 5: Clinical/Bioequivalence

• Bioequivalence study report or WHO PQ certificate

Local Agent Requirements: The Mandatory Local Representative

Zambia's local agent requirements are straightforward and similar to other Southern African markets.

What Your Zambian Agent Must Have:

• Valid ZAMRA pharmaceutical import license
• Physical warehouse in Lusaka or other major city (Kitwe, Livingstone)
• Qualified pharmacist on staff
• Experience with ZAMRA registration and ZAMSC tenders
• Cold chain capability (for temperature-sensitive products)

Selecting Your Agent:

• Zambia has approximately 20-30 licensed pharmaceutical importers
• Key players include: Afro-pharma, Medreich Zambia, Pharmaccess, and various private importers
• Choose an agent with experience in your therapeutic category and a track record of successful ZAMRA registrations
• Ask about their ZAMSC tender experience—winning government tenders requires relationships and logistics capability

SADC Alignment & ZaZiBoNa Harmonization

This is the most important strategic consideration for Zambia.

The ZaZiBoNa Collaborative Registration Process:

ZaZiBoNa (Zambia, Zimbabwe, Botswana, Namibia) is a SADC harmonization initiative that also includes South Africa as an observer. This collaborative registration process allows a single dossier assessment to be recognized by multiple participating countries.

How ZaZiBoNa works with Zambia:

1. You submit one dossier to the ZaZiBoNa collaborative process through a reference national regulator (which could be ZAMRA).
2. A joint team of experts from participating countries assesses the dossier.
3. Once approved at the collaborative level, you obtain individual national registrations from each country—but the scientific assessment is done once.
4. ZAMRA accepts the ZaZiBoNa assessment and typically issues the national registration within 1-3 months.

Benefits of Using ZaZiBoNa for Zambia:

• Faster than standalone ZAMRA registration (6-10 months assessment vs. 8-14 months)
• Lower total cost for multi-country entry (Zambia, Zimbabwe, Botswana, Namibia, potentially South Africa)
• One set of queries instead of multiple
• ZAMRA trusts the collaborative assessment

Using Zambia as Your ZaZiBoNa Reference State:

Zambia can serve as your reference state for the ZaZiBoNa process. This means:

• You submit to ZAMRA as the lead regulator
• ZAMRA coordinates with other participating countries
• Once ZAMRA approves, other countries fast-track

Import Permits & Port Clearance (Dar es Salaam & Durban)

Zambia is landlocked. Pharmaceutical imports arrive via the ports of Dar es Salaam (Tanzania) or Durban (South Africa) and are transported by road or rail to Lusaka.

The Import Permit Process:

1. Your Zambian agent applies for an import permit from ZAMRA via the online portal.
2. ZAMRA issues the permit (typically 5-10 working days).
3. The permit is valid for that specific shipment.

Two Primary Routes:

Route 1: Dar es Salaam (Tanzania) to Lusaka

• Most common route (60-70% of imports)
• Clear Tanzania customs at Dar es Salaam port
• Transport by road (5-7 days to Lusaka via Tunduma border)
• Clear Zambia customs at Nakonde or Lusaka

Route 2: Durban (South Africa) to Lusaka

• Used for 30-40% of imports
• Clear South Africa customs at Durban port
• Transport by road (7-10 days to Lusaka via Beitbridge border)
• Clear Zambia customs at Chirundu or Livingstone

Timelines & Costs:

• Dar es Salaam clearance: 5-10 days
• Transport to Lusaka: 5-7 days
• Lusaka clearance: 2-5 days
• Total: 12-22 days from ship arrival to Lusaka warehouse
• Transport cost (Dar es Salaam-Lusaka): $4,000-7,000 per 20-foot container
• Transport cost (Durban-Lusaka): $5,000-8,000 per 20-foot container

GMP Compliance & Facility Inspections

ZAMRA's GMP requirements are aligned with WHO GMP standards.

GMP Evidence ZAMRA Accepts:

• WHO Prequalification (highest acceptance - waives inspection)
• SRA inspection (US FDA, EMA, SAHPRA) within last 3 years
• SADC joint inspection (ZaZiBoNa)
• ZAMRA-conducted inspection (if no other evidence)

When Does ZAMRA Conduct Its Own Inspection?

• First-time registration without WHO PQ or SRA evidence
• Suspected GMP issues
• High-risk products (injectables, biologics)

Inspection Process:

1. ZAMRA notifies your agent (6-8 weeks notice)
2. Fee: $7,000-12,000 plus travel expenses
3. Inspectors visit for 3-4 days
4. CAPA plan required for findings

Costs, Timelines & Budget Planning

Zambia offers moderate costs and reasonable timelines—good value in Southern Africa.

Official ZAMRA Fees (Approximate)

• Application fee: ZMW 2,000-5,000 ($80-200)
• Evaluation fee: ZMW 5,000-15,000 ($200-600)
• Registration certificate: ZMW 3,000-8,000 ($120-320)
• Annual retention fee: ZMW 1,000-3,000 ($40-120) per product
• Import permit fee: ZMW 500-1,000 ($20-40) per shipment

Third-Party Costs

• Regulatory consultant fees: $7,000-15,000 per product
• Document legalization: $1,000-2,500
• GMP inspection (if required): $8,000-15,000 plus travel
• Bioequivalence study: $50,000-150,000 if new study needed
• Stability studies: $10,000-25,000
• Local agent fees: $5,000-12,000 annually

Total Estimated Cost Per Product:

• Generic with WHO PQ (fastest): $10,000-20,000
• Generic with ZaZiBoNa: $12,000-25,000 (but covers multiple countries)
• Standard generic (well-prepared): $15,000-30,000
• Generic with ZAMRA inspection: $25,000-40,000

Timelines:

• WHO PQ Fast-Track: 4-7 months
• ZaZiBoNa (collaborative assessment): 6-10 months plus national steps
• Standard generic (well-prepared): 8-12 months
• Standard generic (poor dossier, delays): 12-18 months

The Tender System: Zambia Medicines Supply Chain (ZAMSC)

Zambia's public sector procurement is centralized through the Zambia Medicines Supply Chain (ZAMSC) (formerly Medical Stores Limited), which purchases essential medicines for government health facilities.

How ZAMSC Tenders Work:

1. ZAMSC publishes tender announcements for specific products (by INN name, dosage form, strength).
2. Eligible suppliers (registered importers with ZAMRA-registered products) submit bids.
3. ZAMSC evaluates bids based on:
   • Price (40-50% weight) - Lowest price wins
   • Product quality (30-40% weight) - WHO PQ preferred
   • Supplier reliability (20% weight) - Previous performance, delivery history
4. Winning bids receive contracts for specific quantities, delivered to ZAMSC central warehouses in Lusaka and other regional hubs.

Private Sector Opportunity:

The private sector accounts for 30-40% of the Zambian pharmaceutical market. Private pharmacies and hospitals purchase registered products through distributors. Margins are higher than ZAMSC tenders, but volumes are lower.

Common Pitfalls & Rejection Reasons

• Invalid or Expired CPP: Less than 2 years old, WHO format required
• Missing Legalization: All foreign documents must be legalized
• Incorrect Reference Product for BE: Must use Zambia-registered reference
• Inadequate Stability Data: Zone IV (tropical) recommended
• GMP Certificate Issues: Expired or not from recognized authority
• No Local Agent Agreement: Valid agent license must be on file
• Product Sample Fails ZAMRA Testing: Immediate rejection
• Uncompetitive Pricing: For ZAMSC tenders, price is primary factor
• Incomplete Dossier (Missing Modules): ZAMRA requires all 5 CTD modules

Post-Registration Obligations & Renewal

• Annual Retention Fees: Payable each year via ZAMRA portal
• Variations: Changes require ZAMRA approval; timeline 3-6 months
• Renewal: Every 5 years, start 6-9 months before expiry
• Pharmacovigilance: Your agent must report adverse events to ZAMRA; PSURs every 2 years
• Post-Market Surveillance: ZAMRA samples products; failures lead to recalls
• Tender participation: Actively bid on ZAMSC tenders for volume

Conclusion: Your Zambia Entry Strategy

Zambia is a solid entry point for pharmaceutical exporters targeting Southern Africa. The market is accessible, the regulator is functional, and the SADC harmonization framework (ZaZiBoNa) allows you to leverage one registration for multiple countries.

Your Zambia registration checklist:

• ✓ Find an experienced Zambian agent with ZAMRA license and ZAMSC tender experience
• ✓ Obtain WHO Prequalification for your product (strongly recommended for tenders)
• ✓ Execute and legalize Power of Attorney
• ✓ Obtain valid CPP (WHO format, less than 2 years old)
• ✓ Prepare CTD dossier (English only, no translations needed)
• ✓ Budget $15,000-30,000 per product
• ✓ Plan for 8-12 months for registration (4-7 months with WHO PQ)
• ✓ Use the ZaZiBoNa harmonization pathway if targeting multiple SADC markets
• ✓ Develop competitive pricing for ZAMSC tenders
• ✓ Hire a local regulatory consultant with ZAMRA relationships
• ✓ Build private sector distribution while pursuing tenders

Is Zambia worth it? Yes, for most pharmaceutical exporters targeting Southern Africa. The market is large enough (20M people), the regulatory system is functional, and the SADC access (via ZaZiBoNa) multiplies your opportunities. Zambia is not as sophisticated as South Africa or as large as Tanzania, but it's a stable, predictable, and profitable market for compliant manufacturers.

Start with Zambia as your SADC reference state. Register your product, win ZAMSC tenders, build private distribution, then expand to Zimbabwe, Botswana, and Namibia using the ZaZiBoNa collaborative registration. Zambia is the quiet achiever of Southern African pharma—not flashy, but reliable and rewarding.